Background The clinical course of gastric lymphoma is heterogeneous and clinical symptoms and some factors have been related to prognosis. Objective The present study aims to identify prognostic factors in gastric diffuse B-cell non-Hodgkin lymphoma diagnosed and treated in different countries. Methods A consecutive series of gastric diffuse B-cell non-Hodgkin lymphoma patients diagnosed and treated in Brazil, Portugal and Italy, between February 2008 and December 2014 was evaluated. Results Of 104 patients, 57 were female and the median age was 69 years (range: 28–88). The distribution of the age-adjusted international prognostic index was 12/95 (13%) high risk, 20/95 (21%) high-intermediate risk and 63/95 (66%) low/low-intermediate risk. Symptoms included abdominal pain (63/74), weight loss (57/73), dysphagia (37/72) and nausea/vomiting (37/72). Bulky disease was found in 24% of the cases, anemia in 33 of 76 patients and bleeding in 22 of 72 patients. The median follow-up time was 25 months (range: 1–77 months), with 1- and 5-year survival rates of 79% and 76%, respectively. The multivariate Cox Regression identified the age-adjusted international prognostic index as a predictor of death (hazard risk: 3.62; 95% confidence interval: 2.21–5.93; p-value <0.0001). Conclusions This series identified the age-adjusted international prognostic index as predictive of mortality in patients treated with conventional immunochemotherapy.

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients / Delamain, Marcia Torresan; da Silva, Maria Gomes; Miranda, Eliana Cristina Martins; Desterro, Joana; Luminari, Stefano; Fedina, Anna; Merli, Francesco; Chiattone, Carlos Sergio; Pagnano, Katia Borgia Barbosa; Federico, Massimo; de Souza, Carmino Antonio. - In: REVISTA BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. - ISSN 1516-8484. - 38:3(2016), pp. 247-251. [10.1016/j.bjhh.2016.04.010]

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients

Luminari, Stefano
Writing – Review & Editing
;
Federico, Massimo
Writing – Review & Editing
;
2016

Abstract

Background The clinical course of gastric lymphoma is heterogeneous and clinical symptoms and some factors have been related to prognosis. Objective The present study aims to identify prognostic factors in gastric diffuse B-cell non-Hodgkin lymphoma diagnosed and treated in different countries. Methods A consecutive series of gastric diffuse B-cell non-Hodgkin lymphoma patients diagnosed and treated in Brazil, Portugal and Italy, between February 2008 and December 2014 was evaluated. Results Of 104 patients, 57 were female and the median age was 69 years (range: 28–88). The distribution of the age-adjusted international prognostic index was 12/95 (13%) high risk, 20/95 (21%) high-intermediate risk and 63/95 (66%) low/low-intermediate risk. Symptoms included abdominal pain (63/74), weight loss (57/73), dysphagia (37/72) and nausea/vomiting (37/72). Bulky disease was found in 24% of the cases, anemia in 33 of 76 patients and bleeding in 22 of 72 patients. The median follow-up time was 25 months (range: 1–77 months), with 1- and 5-year survival rates of 79% and 76%, respectively. The multivariate Cox Regression identified the age-adjusted international prognostic index as a predictor of death (hazard risk: 3.62; 95% confidence interval: 2.21–5.93; p-value <0.0001). Conclusions This series identified the age-adjusted international prognostic index as predictive of mortality in patients treated with conventional immunochemotherapy.
38
3
247
251
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients / Delamain, Marcia Torresan; da Silva, Maria Gomes; Miranda, Eliana Cristina Martins; Desterro, Joana; Luminari, Stefano; Fedina, Anna; Merli, Francesco; Chiattone, Carlos Sergio; Pagnano, Katia Borgia Barbosa; Federico, Massimo; de Souza, Carmino Antonio. - In: REVISTA BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. - ISSN 1516-8484. - 38:3(2016), pp. 247-251. [10.1016/j.bjhh.2016.04.010]
Delamain, Marcia Torresan; da Silva, Maria Gomes; Miranda, Eliana Cristina Martins; Desterro, Joana; Luminari, Stefano; Fedina, Anna; Merli, Francesco; Chiattone, Carlos Sergio; Pagnano, Katia Borgia Barbosa; Federico, Massimo; de Souza, Carmino Antonio
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1516848416300354-main.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 496.51 kB
Formato Adobe PDF
496.51 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1152048
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact